• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于遗传性视网膜变性基因治疗的腺相关病毒载体。

Adeno-associated viral vectors for gene therapy of inherited retinal degenerations.

作者信息

Flannery John G, Visel Meike

机构信息

Neuroscience Division, Department of Molecular and Cell Biology, Helen Wills Neuroscience Institute, University of California, Berkeley, CA, USA.

出版信息

Methods Mol Biol. 2013;935:351-69. doi: 10.1007/978-1-62703-080-9_25.

DOI:10.1007/978-1-62703-080-9_25
PMID:23150381
Abstract

Adeno-associated virus (AAV) vectors are in wide use for in vivo gene transfer for the treatment of inherited retinal disease. AAV vectors have been tested in many animal models and have demonstrated efficacy with low toxicity. In this chapter we describe some of the recent methods for small-scale production of these vectors for use in a laboratory setting in volumes and purity appropriate for testing in small and large animals.

摘要

腺相关病毒(AAV)载体被广泛用于体内基因转移,以治疗遗传性视网膜疾病。AAV载体已在许多动物模型中进行了测试,并显示出低毒性的有效性。在本章中,我们描述了一些近期用于小规模生产这些载体的方法,这些方法适用于实验室环境,所生产的载体的量和纯度适合在小型和大型动物中进行测试。

相似文献

1
Adeno-associated viral vectors for gene therapy of inherited retinal degenerations.用于遗传性视网膜变性基因治疗的腺相关病毒载体。
Methods Mol Biol. 2013;935:351-69. doi: 10.1007/978-1-62703-080-9_25.
2
AAV-mediated gene therapy for retinal disorders: from mouse to man.腺相关病毒介导的视网膜疾病基因治疗:从小鼠到人类
Gene Ther. 2008 Jun;15(11):849-57. doi: 10.1038/gt.2008.66. Epub 2008 Apr 17.
3
Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration.在遗传性视网膜变性小鼠模型中,通过腺相关病毒介导的基因转移挽救光感受器功能。
Gene Ther. 1997 Jul;4(7):683-90. doi: 10.1038/sj.gt.3300440.
4
Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8.使用单链和自互补重组腺相关病毒血清型2/8评估眼部转导。
Gene Ther. 2008 Mar;15(6):463-7. doi: 10.1038/sj.gt.3303074. Epub 2007 Nov 15.
5
Adeno-associated virus mediated gene therapy for retinal degenerative diseases.腺相关病毒介导的视网膜退行性疾病基因治疗
Methods Mol Biol. 2011;807:179-218. doi: 10.1007/978-1-61779-370-7_8.
6
Adeno-associated virus-vectored gene therapy for retinal disease.腺相关病毒载体基因疗法治疗视网膜疾病。
Hum Gene Ther. 2005 Jun;16(6):649-63. doi: 10.1089/hum.2005.16.649.
7
Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.腺相关病毒(AAV)载体介导的视网膜基因递送:策略与应用
Eur J Pharm Biopharm. 2015 Sep;95(Pt B):343-52. doi: 10.1016/j.ejpb.2015.01.009. Epub 2015 Jan 20.
8
Adeno-associated virus (AAV) based gene therapy for eye diseases.基于腺相关病毒(AAV)的眼科疾病基因治疗。
Cell Tissue Bank. 2011 May;12(2):105-10. doi: 10.1007/s10561-011-9243-7. Epub 2011 Feb 23.
9
Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.重组腺相关病毒介导的基因转移用于治疗视网膜变性的实际考虑因素。
J Gene Med. 2003 Jul;5(7):576-87. doi: 10.1002/jgm.375.
10
Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.严重视网膜营养不良早期发病的基因治疗前景:使用特异性靶向视网膜色素上皮的腺相关病毒血清型4载体恢复RPE65 Briard犬的视力。
Bull Mem Acad R Med Belg. 2006;161(10-12):497-508; discussion 508-9.

引用本文的文献

1
Truncated Complement Factor H Y402 Gene Therapy Cures C3 Glomerulonephritis.截短的补体因子H Y402基因疗法治愈C3肾小球肾炎。
bioRxiv. 2024 Sep 21:2024.09.17.613471. doi: 10.1101/2024.09.17.613471.
2
Retinal Explant Culture from Mouse, Human, and Nonhuman Primates and Its Applications in Vision Research.鼠、人和非人灵长类动物的视网膜组织块培养及其在视觉研究中的应用。
Methods Mol Biol. 2025;2848:169-186. doi: 10.1007/978-1-0716-4087-6_11.
3
Identification and Characterization of Retinitis Pigmentosa in a Novel Mouse Model Caused by PDE6B-T592I.
新型PDE6B-T592I突变小鼠模型中视网膜色素变性的鉴定与特征分析
Biomedicines. 2023 Nov 29;11(12):3173. doi: 10.3390/biomedicines11123173.
4
Extended functional rescue following AAV gene therapy in a canine model of LRIT3-congenital stationary night blindness.LRIT3 先天性静止性夜盲犬模型中 AAV 基因治疗后的功能延长恢复。
Vision Res. 2023 Aug;209:108260. doi: 10.1016/j.visres.2023.108260. Epub 2023 May 21.
5
Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges.用于基因治疗的病毒载体系统:进展与生物安全挑战的综合文献综述
Appl Biosaf. 2020 Mar 1;25(1):7-18. doi: 10.1177/1535676019899502.
6
Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies.推进针对眼部疾病的精准药物:从诊断基因组学到个性化疗法。
Front Med (Lausanne). 2022 Jul 15;9:906482. doi: 10.3389/fmed.2022.906482. eCollection 2022.
7
Targeting ON-bipolar cells by AAV gene therapy stably reverses -congenital stationary night blindness.通过 AAV 基因治疗靶向 ON-双极细胞可稳定逆转 -先天性静止性夜盲症。
Proc Natl Acad Sci U S A. 2022 Mar 29;119(13):e2117038119. doi: 10.1073/pnas.2117038119. Epub 2022 Mar 22.
8
Outcomes of progranulin gene therapy in the retina are dependent on time and route of delivery.颗粒蛋白前体基因疗法在视网膜中的疗效取决于给药时间和途径。
Mol Ther Methods Clin Dev. 2021 May 29;22:40-51. doi: 10.1016/j.omtm.2021.05.009. eCollection 2021 Sep 10.
9
Characterization of Gene Therapy Associated Uveitis Following Intravitreal Adeno-Associated Virus Injection in Mice.基因治疗相关性葡萄膜炎的特征:玻璃体内注射腺相关病毒在小鼠模型中的研究。
Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):41. doi: 10.1167/iovs.62.2.41.
10
Amnesia for context fear is caused by widespread disruption of hippocampal activity.情景恐惧遗忘是由海马活动的广泛破坏引起的。
Neurobiol Learn Mem. 2020 Nov;175:107295. doi: 10.1016/j.nlm.2020.107295. Epub 2020 Aug 18.